Thomas B. Cooper, MA
- 4Articles
- 15.2KReads
- 2004–2018Active
- 25Collaborators
- 71Citations
About
Thomas B. Cooper, MA, has published extensively on schizophrenia, schizoaffective disorders, and obsessive-compulsive and related disorders. His work includes studies on the effects of atypical antipsychotics in treatment-resistant schizophrenia, prolactin levels in patients treated with various antipsychotics, and the impact of Rapastinel on serum brain-derived neurotrophic factor in obsessive-compulsive disorder. Cooper has also investigated omega-3 polyunsaturated fatty acid status in major depressive disorder with comorbid anxiety. His publications span from 2004 to 2018 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
